日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Development and clinical trial of M701, an Anti-EpCAM × Anti-CD3 bispecific antibody: a targeted intraperitoneal therapy for malignant ascites stemming from advanced solid tumors

M701(一种抗EpCAM × 抗CD3双特异性抗体)的研发和临床试验:一种针对晚期实体瘤引起的恶性腹水的靶向腹腔内疗法

Liu, Rongrui; Lin, Rongbo; Li, Ning; Li, Guiling; Zhang, Tao; Zhao, Jun; Li, Jiayi; Sun, Meili; Wang, Ke; An, Hanxiang; Zhang, Weijie; Xu, Huiting; Zeng, Shan; Zhang, Mingjun; Duan, Wei; Bai, Yuxian; Zhang, Jingdong; Tian, He; Yin, Fei; Kang, Yu; Xu, Qi; Xu, Nong; Deng, Yanhong; Chen, Qing; Li, Yongqiang; Yang, Hongying; Su, Fang; Xiao, Zhenghong; Xiang, Xiaojun; Zhou, Pengfei; Huang, Shaoyi; Zhang, Jing; Xu, Jianming

Exosomal miR-122-5p for regulation of secretory functions of fibroblasts and promotion of breast cancer metastasis by targeting MKP-2: an experimental study.

外泌体 miR-122-5p 通过靶向 MKP-2 调节成纤维细胞的分泌功能并促进乳腺癌转移:一项实验研究

Lv Yun, Li Yue, Zhou Jie, Liu Xin, Wang Dandan, Wang Dongmei, Tong Dandan, Wang Shuhuai, An Hanxiang, Kang Xinmei

Current management of chemotherapy-induced neutropenia in adults: key points and new challenges: Committee of Neoplastic Supportive-Care (CONS), China Anti-Cancer Association Committee of Clinical Chemotherapy, China Anti-Cancer Association

成人化疗引起的粒细胞减少症的当前管理:要点和新挑战:中国抗癌协会肿瘤支持治疗委员会、中国抗癌协会临床化疗委员会

Ba, Yi; Shi, Yuankai; Jiang, Wenqi; Feng, Jifeng; Cheng, Ying; Xiao, Li; Zhang, Qingyuan; Qiu, Wensheng; Xu, Binghe; Xu, Ruihua; Shen, Bo; Luo, Zhiguo; Xie, Xiaodong; Chang, Jianhua; Wang, Mengzhao; Li, Yufu; Shuang, Yuerong; Niu, Zuoxing; Liu, Bo; Zhang, Jun; Zhang, Li; Yao, Herui; Xie, Conghua; Huang, Huiqiang; Liao, Wangjun; Chen, Gongyan; Zhang, Xiaotian; An, Hanxiang; Deng, Yanhong; Gong, Ping; Xiong, Jianping; Yao, Qinghua; An, Xin; Chen, Cheng; Shi, Yanxia; Wang, Jialei; Wang, Xiaohua; Wang, Zhiqiang; Xing, Puyuan; Yang, Sheng; Zhou, Chenfei

Plasma MiRNA alterations between NSCLC patients harboring Del19 and L858R EGFR mutations

携带Del19和L858R EGFR突变的非小细胞肺癌患者血浆miRNA的改变

Ma, Yihan; Xu, Peiqi; Mi, Yanjun; Wang, Wenyi; Pan, Xiaoyan; Wu, Xiaoting; He, Qi; Liu, Hongming; Tang, Weiwei; An, Hanxiang